Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	30.59M +30.9%
Revenue (ttm)	17.11M +2.4%
Net Income	2.39M -22.6%
EPS	0.25 -22.6%
Shares Out	9.50M
PE Ratio	12.79
Forward PE	n/a
Dividend	0.22 (6.83%)
Ex-Dividend Date	Apr 16, 2026

Volume	550
Average Volume	1,014
Open	3.220
Previous Close	n/a
Day's Range	3.220 - 3.220
52-Week Range	2.630 - 3.350
Beta	0.03
RSI	51.81
Earnings Date	Feb 12, 2026

About ASE:HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 234
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2025, ASE:HPIC's revenue was 17.11 million, an increase of 2.39% compared to the previous year's 16.71 million. Earnings were 2.39 million, a decrease of -22.58%.